Pharmacological manipulation of glutamate transport

被引:4
作者
Beretta, S [1 ]
Begni, B [1 ]
Ferrarese, C [1 ]
机构
[1] Univ Milan, Osped San Gerardo, Dept Neurosci & Biomed Technol, I-20052 Monza, MI, Italy
关键词
D O I
10.1358/dnp.2003.16.7.829355
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
L-Glutamic acid acts as the major excitatory neurotransmitter and, at the same time, represents a potential neurotoxin for the mammalian central nervous system (CNS). The termination of excitatory transmission and the maintenance of physiologic levels of extracellular glutamate, which is necessary to prevent excitotoxicity, are prominently mediated by a family of high-affinity sodium-dependent excitatory amino acid transporters (EAATs). Five subtypes of EAATs have been cloned, possessing distinct pharmacology, localization, sensitivity to transport inhibitors and modulatory mechanisms. Expression and activity of EAATs have been shown to be amenable to fine endogenous and, potentially, pharmacological regulation by substrate itself, growth factors, second messengers, hormones, biological oxidants, inflammatory mediators and pathological conditions. The present review describes basic pharmacological studies, mostly performed on animal models or cell preparations, in order to obtain an updated picture of the known regulatory mechanisms of single EAAT expression and activity. New insight into molecular pathways involved in EAAT regulation will allow-pharmacological manipulation of excitatory CNS activity, possibly avoiding adverse effects of glutamate receptor blockade. (C) 2003 Prous Science, All rights reserved.
引用
收藏
页码:435 / 445
页数:11
相关论文
共 101 条
[81]   PHENCYCLIDINE TREATMENT IN MICE - EFFECTS ON PHENCYCLIDINE BINDING-SITES AND GLUTAMATE UPTAKE IN CEREBRAL-CORTEX PREPARATIONS [J].
SARANSAARI, P ;
LILLRANK, SM ;
OJA, SS .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 93 (01) :47-59
[82]   Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons [J].
Schlag, BD ;
Vondrasek, JR ;
Munir, M ;
Kalandadze, A ;
Zelenaia, OA ;
Rothstein, JD ;
Robinson, MB .
MOLECULAR PHARMACOLOGY, 1998, 53 (03) :355-369
[83]  
SHARP FR, 1998, STROKE PATHOPHYSIOLO, P51
[84]   Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase [J].
Sims, KD ;
Straff, DJ ;
Robinson, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :5228-5237
[85]   Structural features of the glutamate transporter family [J].
Slotboom, DJ ;
Konings, WN ;
Lolkema, JS .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1999, 63 (02) :293-+
[86]   ASSIGNMENT OF THE GENE CODING FOR THE HUMAN HIGH-AFFINITY GLUTAMATE TRANSPORTER EAAC1 TO 9P24 - POTENTIAL ROLE IN DICARBOXYLIC AMINOACIDURIA AND NEURODEGENERATIVE DISORDERS [J].
SMITH, CP ;
WEREMOWICZ, S ;
KANAI, Y ;
STELZNER, M ;
MORTON, CC ;
HEDIGER, MA .
GENOMICS, 1994, 20 (02) :335-336
[87]   Regulation of glutamate uptake in astrocytes continuously exposed to ethanol [J].
Smith, TL .
LIFE SCIENCES, 1997, 61 (25) :2499-2505
[88]  
SUTHERLAND ML, 2002, ENHANCEMENT GLUTAMAT
[89]  
Swanson RA, 1997, J NEUROSCI, V17, P932
[90]   Astrocytic alterations induced by HTLV type 1-infected T lymphocytes:: A role for Tax-1 and tumor necrosis factor α [J].
Szymocha, R ;
Akaoka, H ;
Brisson, C ;
Beurton-Marduel, P ;
Chalon, A ;
Bernard, A ;
Didier-Bazes, M ;
Belin, MF ;
Giraudon, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (16) :1723-1729